Galderma Group AG (GDERF)
Galderma Group Market Cap : 46.81B for April 24, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| EvoNext Holdings SA | 8.149M |
| Kuros Biosciences Ltd. | 1.097B |
| Basilea Pharmaceutica AG | 846.75M |
| Santhera Pharmaceuticals Holding AG | 284.73M |
| BeOne Medicines Ltd. | 33.39B |
Market Cap Related Metrics
| PE Ratio | 77.15 |
| PS Ratio | 9.090 |
| Price to Free Cash Flow | 45.91 |
| Price | 199.55 |
| Earnings Yield | 1.30% |
| Operating PE Ratio | 56.01 |
| Normalized PE Ratio | 69.74 |